See If You Qualify For The Migraine Research trial
At Palm Beach Research, we have COVID-19 studies enrolling participants now. The purpose of this research study is to demonstrate the efficacy, safety, and tolerability of STS101 (Dihydroergotamine Nasal Powder) in the acute treatment of Migraines.
Qualified Participants will receive:
- Study-related vaccine at no cost
- Study-related medical exams at no cost
- Compensation up to $300 for time and travel
How It Works
Subscribe To Our Newsletter
Subscribe to learn more about our clinical research trials, current and upcoming studies.